GSK's Q1 2025 earnings will reveal progress in specialty medicines amid regulatory headwinds. Learn what to watch when the ...

Topline interim dataset from GALAXIES Lung-201 with >240 patients anticipated in 2Q25 - Interim datasets from GALAXIES H&N-202 and TIG-006 HNSCC with ~200 patients anticipated in 2025 - Cash balance ...

HSBC downgraded several major biotech names this week, citing macroeconomic sensitivities, tariff risks, and growing pressure from regulatory changes. Most notably, the bank downgraded Lilly to Reduce ...

GSK PLC closed 22.73% below its 52-week high of £18.24, which the company reached on May 16th.

NET PROFIT FORECAST: Net profit is expected to rise to 1.67 billion pounds from 1.05 billion pounds, according to a consensus provided by the company. London-listed shares in GSK are up 4.1% since the ...

We expect GSK's specialty products like Cabenuva, Juluca, Dovato, Nucala, Ojjaara, Jemperli and Trelegy Ellipta to have driven first-quarter sales performance.

British equities ended higher on Monday with heavyweight healthcare companies leading gains in the benchmark index, while U.S ...

The FTSE 100 index starts the week on its best run since 2019 after closing Friday’s session in positive territory for the ...

Compared with a control group who had prescriptions for other inhaled steroids (including the authorized generic of ...

We recently published a list of the 11 Best Undervalued UK Stocks to Buy Right Now. In this article, we are going to take a ...

SHANGHAI] China exempted some US imports from its steep tariffs in a sign on Friday (Apr 25) that the trade war between the ...

Home First Finance Company India Ltd recorded volume of 4.22 lakh shares by 10:47 IST on BSE, a 25.89 times surge over two-week average daily volume of 16300 shares ...